Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8539)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 8, 2017 (publication date) through Jun 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fujii H, Umemura A, Nishikawa T, Yamaguchi K, Moriguchi M, Nakamura H, Yasui K, Minami M, Tanaka S, Ishikawa H, Kimura H, Takami S, Nagao Y, Shima T, Itoh Y. Real-world efficacy of daclatasvir and asunaprevir with respect to resistance-associated substitutions. World J Hepatol 2017; 9(25): 1064-1072 [PMID: 28951778 DOI: 10.4254/wjh.v9.i25.1064] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i25/1064.htm |
| Number | Citing Articles |
| 1 |
Shimaa Kamel, Hagar Elessawy, Ossama Ashraf, Ahmed Elbaz, Hany Dabbous, Manal El-Sayed, Safaa Ali, Heba Kamel. Effectiveness of Direct-Acting Antivirals in Treatment of Elderly Egyptian Chronic Hepatitis C Patients. Gastroenterology Insights 2021; 12(3): 336 doi: 10.3390/gastroent12030031
|
| 2 |
Jae Young Oh, Byung Seok Kim, Chang Hyeong Lee, Jeong Eun Song, Heon Ju Lee, Jung Gil Park, Jae Seok Hwang, Woo Jin Chung, Byoung Kuk Jang, Young Oh Kweon, Won Young Tak, Soo Young Park, Se Young Jang, Jeong Ill Suh, Sang Gyu Kwak. Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world . The Korean Journal of Internal Medicine 2019; 34(4): 794 doi: 10.3904/kjim.2017.368
|
| 3 |
Fabián Aldunate, Natalia Echeverría, Daniela Chiodi, Pablo López, Adriana Sánchez-Cicerón, Alvaro Fajardo, Martín Soñora, Juan Cristina, Nelia Hernández, Pilar Moreno. Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients. Disease Markers 2018; 2018: 1 doi: 10.1155/2018/2514901
|
| 4 |
Xiaoyuan Xu, Bo Feng, Yujuan Guan, Sujun Zheng, Jifang Sheng, Xingxiang Yang, Yuanji Ma, Yan Huang, Yi Kang, Xiaofeng Wen, Jun Li, Youwen Tan, Qing He, Qing Xie, Maorong Wang, Ping An, Guozhong Gong, Huimin Liu, Qin Ning, Rui Hua, Bo Ning, Wen Xie, Jiming Zhang, Wenxiang Huang, Yongfeng Yang, Minghua Lin, Yingren Zhao, Yanhong Yu, Jidong Jia, Dongliang Yang, Liang Chen, Yinong Ye, Yuemin Nan, Zuojiong Gong, Quan Zhang, Peng Hu, Fusheng Wang, Yongguo Li, Dongliang Li, Zhansheng Jia, Jinlin Hou, Chengwei Chen, Jinzi J. Wu, Lai Wei. Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China. Journal of Clinical and Translational Hepatology 2019; 7(3): 1 doi: 10.14218/JCTH.2019.00033
|
| 5 |
Hideki Fujii, Hiroyuki Kimura, Masayuki Kurosaki, Chitomi Hasebe, Takehiro Akahane, Hitoshi Yagisawa, Keizo Kato, Hideo Yoshida, Jun Itakura, Shinya Sakita, Takashi Satou, Kazuhiko Okada, Atsunori Kusakabe, Yuji Kojima, Masahiko Kondo, Atsuhiro Morita, Akihiro Nasu, Takashi Tamada, Hiroaki Okushin, Haruhiko Kobashi, Keiji Tsuji, Kouji Joko, Chikara Ogawa, Yasushi Uchida, Akeri Mitsuda, Tetsuro Sohda, Yasushi Ide, Namiki Izumi. Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis. Hepatology Research 2018; 48(9): 746 doi: 10.1111/hepr.13070
|
| 6 |
Hidenori Toyoda, Masanori Atsukawa, Koichi Takaguchi, Tomonori Senoh, Kojiro Michitaka, Atsushi Hiraoka, Shinichi Fujioka, Chisa Kondo, Tomomi Okubo, Haruki Uojima, Toshifumi Tada, Hirohito Yoneyama, Tsunamasa Watanabe, Toru Asano, Toru Ishikawa, Hideyuki Tamai, Hiroshi Abe, Keizo Kato, Kunihiko Tsuji, Chikara Ogawa, Noritomo Shimada, Etsuko Iio, Akihiro Deguchi, Ei Itobayashi, Shigeru Mikami, Akio Moriya, Hironao Okubo, Joji Tani, Akihito Tsubota, Yasuhito Tanaka, Tsutomu Masaki, Katsuhiko Iwakiri, Takashi Kumada. Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan. Journal of Gastroenterology 2018; 53(12): 1276 doi: 10.1007/s00535-018-1473-z
|
| 7 |
Koichi Takaguchi, Hidenori Toyoda, Akemi Tsutsui, Yoshiyuki Suzuki, Makoto Nakamuta, Michio Imamura, Tomonori Senoh, Takuya Nagano, Toshifumi Tada, Yoshihiko Tachi, Atsushi Hiraoka, Kojiro Michitaka, Hiroshi Shibata, Kouji Joko, Hironao Okubo, Kunihiko Tsuji, Shintaro Takaki, Tsunamasa Watanabe, Chikara Ogawa, Kazuaki Chayama, Takashi Kumada, Masatoshi Kudo, Hiromitsu Kumada. Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan. Journal of Gastroenterology 2019; 54(8): 742 doi: 10.1007/s00535-019-01568-8
|
| 8 |
Jieun Lee, Sang Bong Ahn, Sun Young Yim, Jihyun An, Dae Won Jun, Min Jung Ko, Dong Ah Park, Jeong‐Ju Yoo. Efficacy and safety of direct‐acting antiviral therapy for hepatitis C virus in elderly patients (≥65 years old): A systematic review and meta‐analysis. Journal of Viral Hepatitis 2022; 29(7): 496 doi: 10.1111/jvh.13679
|
| 9 |
Rosanna Villani, Matteo Monami, Francesca Di Cosimo, Gilda Fioravanti, Edoardo Mannucci, Gianluigi Vendemiale, Gaetano Serviddio. Direct‐acting antivirals for HCV treatment in older patients: A systematic review and meta‐analysis. Journal of Viral Hepatitis 2019; 26(11): 1249 doi: 10.1111/jvh.13169
|